AI entity
product-launch is the sole category represented across all 1 tracked stories. CyPath Lung is most often covered alongside Insider Monkey, which appears in 1 of these 1 story. We currently track 1 AI story that mention CyPath Lung, all published on September 5, 2026.
Last mentioned: 22h ago
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
product-launch is the sole category represented across all 1 tracked stories. CyPath Lung is most often covered alongside Insider Monkey, which appears in 1 of these 1 story. We currently track 1 AI story that mention CyPath Lung, all published on September 5, 2026. Each carries 2 original sources on average.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 16 AI stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering CyPath Lung. Shared-story counts are live from our verified record — not editorial picks.
bioAffinity's AI and flow cytometry approach to lung cancer detection saw test volume climb 216% year over year. The new post-treatment surveillance initiative could scale algorithm-driven diagnostics into longitudinal monitoring.
Source: finance.yahoo.com · insidermonkey.com
CyPath Lung is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
